XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events

Earned $35 million milestone payment as NIS793 entered Phase 3 clinical study in metastatic pancreatic cancer Received $1.2 million from three milestone payments, two of which were from a single... | March 8, 2022

Related Keywords

Kathy Vincent ,Juliane Snowden ,Justin Frantz ,Jim Neal ,Silicon Valley Bank ,Rezolute Inc ,Drug Administration ,Compugen ,Novartis ,Exchange Commission ,Securities Exchange ,Novartis International ,Corporation Nasdaq ,Globenewswire Inc ,Orphan Drug Designation ,Rare Pediatric Disease Designation ,Fast Track Designation ,Last October ,Chief Executive Officer ,Antibody License Agreement ,Valley Bank ,Securities Act ,Securities Exchange Act ,Xoma Corporation Stock Exchange ,News ,Information ,Press Release ,Arned ,Billion ,Milestone ,Payment ,Us ,Is793 ,Ntered ,Hase , ,Linical ,Metastatic ,Pancreatic ,Dancer ,Eceived ,Rom ,Three ,Two ,F ,Which ,Were ,Rom Xoma Us98419j2069 ,